Table A-15. Mean yields and agronomic data from Milan, TN Non-Irrigated, MG-4E

Table A-15-a. Mean† yield and agronomic traits of 29 Maturity Group IV Early (4.0 – 4.4) soybean varieties evaluated in small plot replicated trials without irrigation at the AgResearch and Education Center at Milan in Milan, Tennessee during 2021. Analysis included variety performance over a 1 yr (2021), 2 yr (2020-2021), and 3 yr (2019-2021) period.

VarietyHerbicide Pkg†Avg. Yield§
(bu/ac)
Moisture at Harvest
(%)
Plant Height
(in.)
Lodging‖
(1-5)
Maturity
(DAP)
1 yr2 yr3 yr1 yr2 yr3 yr1 yr2 yr3 yr1 yr2 yr3 yr1 yr2 yr3 yr
USG 7431ETE359C-G60B11.3F12.3C39F-I41D1.0C1.7AB137B-D132B
Progeny P4521XFSXF, STS58D-G12.0B-F41C-G1.0C141A
Innvictis A4571XFXF58D-G12.0B-F37I1.0C137B-D
Credenz CZ 4562 XFXF56E-G12.0B-F45A1.3BC137B-D
Asgrow AG42XF1XF, STS56E-G11.8B-F44A-C1.3BC134E
Progeny P4431E3E354F-H11.4EF40E-I1.3BC137B-D
Progeny P4541E3E354GH12.1B-F43A-E1.7A-C134E
Credenz CZ 4202 XFXF48H12.4A-D43A-E1.7A-C134E
Average61636712.012.812.34144461.41.61.6136132129
Standard Error3330.31.00.81320.30.60.3153
L.S.D..057N.S.N.S.0.90.5N.S.33N.S.N.S.N.S.N.S.232
C.V.71110433556122

† Varieties that have any MS letter in common are not significantly different at the 5% level of probability. Values highlighted in light orange are above average for a given trait, MS letters highlighted in dark orange are in the “A group”, indicating no statistical difference from the top-performing variety, for a given trait.

* Asterisks after a name indicate the number of preceding consecutive years in the top-performing “A” group.

‡ For a full description of abbreviated biotech traits, see table 31.

§All yields are adjusted to 13% moisture.

‖ Lodging was evaluated on a a scale of 1 (no lodging) to 5 (complete lodging).

Table A-15-b. Mean† yield and agronomic traits of 29 Maturity Group IV Early (4.0 – 4.4) soybean varieties evaluated in small plot replicated trials without irrigation at the AgResearch and Education Center at Milan in Milan, Tennessee during 2021. Analysis included variety performance over a 1 yr (2021), 2 yr (2020-2021), and 3 yr (2019-2021) period.

 

VarietyHerbicide Pkg†Avg. Yield§
(bu/ac)
SDS DI††
(%)
SDS DS††
(1-9)
SDS†† DX
(DI x DS/9)
1 yr2 yr3 yr1 yr1 yr1 yr
NK Seed NK44-J4XFSXF, STS68A1.7EF0.5FG0.3FG
Local Seed Co. LS4299XSR2X, STS68A61B66A1.7EF0.5FG0.3FG
Dyna-Gro S41XS98****R2X, STS67AB70A71A0F0G0G
Local Seed Co. LS4415XFXF66A-C18.3B4AB8.5BC
Dyna-Gro S43EN61E366A-C60B6.7C-F1.5D-G1.1E-G
Dyna-Gro S45ES10*E3, STS65A-D65AB10B-E2C-F3.3D-G
Xitavo XO 4371EE364A-D1.7EF1E-G0.6FG
Dyna-Gro S43XF51XF64A-D6.7C-F1.3D-G1.5E-G
AgriGold G4100XFXF63A-E0F0G0G
Innvictis A4411XFXF62A-E3.3D-F0.7FG0.7FG
Progeny P4505RXS*R2X, STS62A-E60B13.3BC2.7B-E4.1D-G
Dyna-Gro S43XS70R2X, STS62A-E64AB65A6.7C-F1.2E-G1.4E-G
Progeny P4501XFSXF, STS62A-E16.7B3.2B-D6.1B-D
Innvictis A4371XFXF62A-F0F0G0G
Local Seed Co. LS4517XFSXF, STS62A-F5C-F1E-G1.7E-G
Asgrow AG45XF0XF, STS61A-F18.3B3.8BC9.2B
NK Seed NK43-V8XFXF61A-G5C-F2.7B-E2.4D-G
Innvictis A4251XFXF60B-G11.7B-D2.8B-E3.8D-G
Dyna-Gro S41EN72E360B-G5C-F1.5D-G1.2E-G
USG 7441XFXF60C-G0F0G0G
Armor A45-D20R2X59C-G3.3D-F0.7FG0.7FG
USG 7431ETE359C-G60B5C-F1.3D-G1.2E-G
Progeny P4521XFSXF, STS58D-G1.7EF0.7FG0.4FG
Innvictis A4571XFXF58D-G11.7B-D3.5BC4.5C-F
Credenz CZ 4562 XFXF56E-G11.7B-D3.5BC5.3B-E
Asgrow AG42XF1XF, STS56E-G0F0G0G
Progeny P4431E3E354F-H0F0G0G
Progeny P4541E3E354GH55.1A6A36.6A
Credenz CZ 4202 XFXF48H0F0G0G
Average6163677.61.63.3
Standard Error3333.20.71.6
L.S.D..057N.S.N.S.8.91.94.3
C.V.71110

† Varieties that have any MS letter in common are not significantly different at the 5% level of probability. Values highlighted in light orange are above average for a given trait, MS letters highlighted in dark orange are in the “A group”, indicating no statistical difference from the top-performing variety, for a given trait.

* Asterisks after a name indicate the number of preceding consecutive years in the top-performing “A” group.

‡ For a full description of abbreviated biotech traits, see table 31.

§All yields are adjusted to 13% moisture. †† SDS was evaluated as disease incidence (percentage), disease severity (1 to 9, with 1 indicating no disease), and disease index (DI x DS/9). Evaluated in mid-September. 

Scroll to Top